Premium
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real‐world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group
Author(s) -
Michallet AnneSophie,
Campidelli Arnaud,
Lequeu Helene,
Dilhuydy MarieSarah,
Tournilhac Olivier,
Fornecker LucMatthieu,
Dupuis Jehan,
Cymbalista Florence,
De Guibert Sophie,
Delmer Alain,
Vilque JeanPierre,
Ghez David,
Leblond Veronique,
Subtil Fabien,
Feugier Pierre,
Ysebaert Loic
Publication year - 2017
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24715
Subject(s) - ibrutinib , refractory (planetary science) , medicine , chronic lymphocytic leukemia , leukemia , hematology , oncology , physics , astrobiology
International audienc